Cathepsin D (cath-D) overexpression in breast cancer cells is associated wi
th increased risk of metastasis in patients according to several clinical s
tudies. No alterations of pro-cath-D structure or activation have been demo
nstrated in cancer cells. However, overexpression and dysrouting of pro-cat
h-D in illegitimate compartments could have consequences on tumor progressi
on. Transfection of a human cDNA cath-D expression vector increases the met
astatic potential of 3Y1-Ad12 embryonic rat tumorigenic cells when intraven
ously injected into nude mice. The mechanism by which cath-D increases the
incidence of clinical metastasis seems to involve increased cell growth and
decreased contact inhibition rather than escape of cancer cells through th
e basement membrane. Different mechanisms are discussed by which cath-D cou
ld act as a protease following its activation or as a ligand of different m
embrane receptors at a more neutral pH.